MMP-3 can distinguish isolated PMR from PMR with GCA: A retrospective study regarding PMR and GCA in Japan
Shoichi Fukui1,2, Takahiro Nunokawa3, Satomi Kobayashi1
1a Department of Rheumatology , Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital , Tokyo , Japan.
Objective:
We sought to identify clinical features at diagnosis that can distinguish isolated polymyalgia rheumatica (PMR) without giant cell arteritis (GCA) from PMR with GCA, and clinical features at diagnosis of isolated PMR that can predict subsequent relapse and corticosteroid discontinuation.
Methods:
A retrospective study of 115 patients with isolated PMR and 29 patients with GCA was performed. A comparison between isolated PMR patients, GCA patients (with or without PMR), and PMR with GCA patients was performed. Predictors of relapse and corticosteroid discontinuation were identified using a logistic regression in the patients with isolated PMR.
Results:
Matrix metalloproteinase-3 (MMP-3) level was significantly different among the patient groups. MMP-3: 230.5 ± 201.5 ng/mL in isolated PMR, 80.5 ± 47.5 ng/mL in GCA (p < 0.01), and 96.8 ± 54.8 ng/mL in PMR with GCA (p = 0.03). In the patients with isolated PMR, female gender (odds ratio [OR], 2.73; 95% confidence interval [CI], 1.16-6.41; p < 0.05) and creatinine (Cr) < 50 μmol/L (OR, 2.48; 95% CI, 1.02-5.99; p < 0.05) were significant prognostic factors that predicted relapse.
Conclusion:
A low level of MMP-3 is an excellent positive predictor for PMR with GCA. Among patients with isolated PMR, female gender and Cr < 50 μmol/L were significant prognostic factors that predicted relapse.
Insights
Low matrix metalloproteinase-3 (MMP-3) levels predict polymyalgia rheumatica with giant cell arteritis (GCA). Female gender and low creatinine predict relapse in isolated PMR patients.
Area of Science:
- Rheumatology
- Clinical Immunology
Background:
- Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are inflammatory conditions.
- Distinguishing isolated PMR from PMR with GCA is clinically important.
- Predicting relapse and corticosteroid discontinuation in isolated PMR aids patient management.
Purpose of the Study:
- Identify clinical features differentiating isolated PMR from PMR with GCA at diagnosis.
- Determine predictors of relapse and corticosteroid discontinuation in isolated PMR.
Main Methods:
- Retrospective study of 115 isolated PMR patients and 29 GCA patients.
- Comparative analysis between isolated PMR, GCA, and PMR with GCA groups.
- Logistic regression used to identify relapse and corticosteroid discontinuation predictors in isolated PMR.
Main Results:
- Matrix metalloproteinase-3 (MMP-3) levels differed significantly between groups: isolated PMR (230.5 ± 201.5 ng/mL), GCA (80.5 ± 47.5 ng/mL), and PMR with GCA (96.8 ± 54.8 ng/mL).
- Low MMP-3 levels were a positive predictor for PMR with GCA.
- In isolated PMR, female gender (OR 2.73) and creatinine < 50 μmol/L (OR 2.48) predicted relapse.
Conclusions:
- Low MMP-3 levels are a strong indicator of PMR with GCA.
- Female gender and low creatinine are significant predictors of relapse in isolated PMR.
- These findings aid in differentiating PMR subtypes and predicting disease course.
More Related Videos
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis III: Medical Management


